‘GOI can consider providing customs duty exemptions to all life saving drugs’
Bourgeoning population, growing incidence of chronic and lifestyle diseases and increasing healthcare costs are calling for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘All excisable goods used for R&D purposes should be exempted from Central Excise Duty’
It is high time that the Government takes a serious note of the issues and concerns of the Indian pharmaceutical industry. The…
‘Invest $4-5 bn each year in the next five years to grow the biotech industry to $100 bn by 2025’
Make bio-manufacturing the next big opportunity after generics for India. Invest $4-5 billion each year (Rs 24,000 to 30,000…
‘A new National Health Policy needs to be rolled out ’
A high level FICCI delegation led by Sidharth Birla, President, FICCI met the Union Health and Family Welfare Minister Dr Harsh…
Restructuring Infrastructure
A series of warning letters and import alerts seem to have convinced pharmaceutical companies to plug the loopholes in plant…
Clustering for comfort
The proposed Cluster Development Programme for the Pharma Sector (CDP-PS), a part of the 12th Five Year Plan, has received a…
Lending a helping hand
Most medium and small sized pharmaceutical companies in India would like to upgrade their facilities but face many hurdles.…
‘We would be able to play our role in helping India’s pharma exports’
Pharmexcil has come into effect in May 2004. Since then it has been liaising between industry and Government to help promote…
‘One window clearance should be made possible’
Firstly, there has to be a separate documented booklet on schemes announced by the Government till today, specially for the…
‘The funding amount provided should be reasonable to meet requirements’
The best scheme for Technology Upgradation Fund Scheme (TUFS) for SMEs should be the one that identifies their need and meets…